Heron Therapeutics's total assets for Q3 2024 were $220.78M, an increase of 1.21% from the previous quarter. HRTX total liabilities were $260.78M for the fiscal quarter, a 1.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.